Business Description
Senzime AB
ISIN : SE0002478776
Total Employee Number:
58Compare
Compare
Traded in other countries / regions
SEZI.Sweden6YC.GermanySNZZF.USA IPO Date
2016-11-21Description
Senzime AB is a medical device company developing precision-based patient monitoring solutions for patients undergoing anesthesia. The company develops and markets precision-based monitoring systems for monitoring neuromuscular function and respiration during and after surgery, as well as for intensive care. Its product portfolio includes Next-generation TetraGraph, TetraGraph connectivity, TetraGraph for pediatric, Classic TetraGraph, and ExSpiron. The TetraGraph system is used in thousands of operating rooms internationally in university hospitals, public, private, military, and veterans hospitals. Senzime has direct sales resources in the USA and Germany and collaborates with distributors and licensees in its other main markets.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 2.54 | |||||
Equity-to-Asset | 0.81 | |||||
Debt-to-Equity | 0.08 | |||||
Debt-to-EBITDA | -0.24 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 2.26 | |||||
Beneish M-Score | -2.48 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 49.6 | |||||
3-Year EBITDA Growth Rate | 24 | |||||
3-Year EPS without NRI Growth Rate | 22.4 | |||||
3-Year FCF Growth Rate | 25.9 | |||||
3-Year Book Growth Rate | -19.4 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 55.99 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 46.74 | |||||
9-Day RSI | 48.28 | |||||
14-Day RSI | 48.23 | |||||
3-1 Month Momentum % | 5.2 | |||||
6-1 Month Momentum % | -7.4 | |||||
12-1 Month Momentum % | -4.56 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.76 | |||||
Quick Ratio | 2.92 | |||||
Cash Ratio | 1.97 | |||||
Days Inventory | 150.52 | |||||
Days Sales Outstanding | 55.55 | |||||
Days Payable | 45.34 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -30.4 | |||||
Shareholder Yield % | -14.83 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 32.74 | |||||
Operating Margin % | -117.16 | |||||
Net Margin % | -120.74 | |||||
EBITDA Margin % | -87.44 | |||||
FCF Margin % | -111.46 | |||||
OCF Margin % | -96.21 | |||||
ROE % | -38.82 | |||||
ROA % | -32.17 | |||||
ROIC % | -40.79 | |||||
3-Year ROIIC % | -960.02 | |||||
ROC (Joel Greenblatt) % | -310.96 | |||||
ROCE % | -31.81 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 6.19 | |||||
PB Ratio | 2.33 | |||||
Price-to-Tangible-Book | 9.57 | |||||
EV-to-EBIT | -5.27 | |||||
EV-to-Forward-EBIT | 19.31 | |||||
EV-to-EBITDA | -6.62 | |||||
EV-to-Forward-EBITDA | 16.58 | |||||
EV-to-Revenue | 5.79 | |||||
EV-to-Forward-Revenue | 8.6 | |||||
EV-to-FCF | -5.19 | |||||
Price-to-GF-Value | 0.4 | |||||
Price-to-Median-PS-Value | 0.06 | |||||
| Price-to-Net-Current-Asset-Value | 15.95 | |||||
Earnings Yield (Greenblatt) % | -18.98 | |||||
FCF Yield % | -17.52 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:SNZZF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Senzime AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 11.06 | ||
| EPS (TTM) ($) | -0.086 | ||
| Beta | 0.7091 | ||
| 3-Year Sharpe Ratio | 0.05 | ||
| 3-Year Sortino Ratio | 0.07 | ||
| Volatility % | 58.41 | ||
| 14-Day RSI | 48.23 | ||
| 14-Day ATR ($) | 0.001182 | ||
| 20-Day SMA ($) | 0.47855 | ||
| 12-1 Month Momentum % | -4.56 | ||
| 52-Week Range ($) | 0.45 - 0.7359 | ||
| Shares Outstanding (Mil) | 157.22 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Senzime AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Senzime AB Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-10-29 | In 117 days | ||
| Third quarter earnings results for 2026 | 2026-10-29 | In 117 days | ||
| Second quarter earnings conference call for 2026 | 2026-07-16 | In 12 days | ||
| Second quarter earnings results for 2026 | 2026-07-16 | In 12 days | ||
| General meeting for 2026 | 2026-05-19 16:00 | 0.48 (+0.00%) | ||
| Annual report for 2025 | 2026-04-24 | 0.48 (+0.00%) | ||
| First quarter earnings conference call for 2026 | 2026-04-22 09:00 | 0.48 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-04-22 08:00 | 0.48 (+0.00%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-02-18 09:00 | 0.62 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-18 | 0.62 (+0.00%) |
Show
Entries
Senzime AB Frequently Asked Questions
What is Senzime AB(SNZZF)'s stock price today?
The current price of SNZZF is $0.48. The 52 week high of SNZZF is $0.74 and 52 week low is $0.45.
When is next earnings date of Senzime AB(SNZZF)?
The next earnings date of Senzime AB(SNZZF) is 2026-07-16.
Does Senzime AB(SNZZF) pay dividends? If so, how much?
Senzime AB(SNZZF) does not pay dividend.
Guru Commentaries on OTCPK:SNZZF
No articles.
Press Release
Articles on Senzime AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers